HGleckman

About Howard Gleckman

This author has not yet filled in any details.
So far Howard Gleckman has created 609 blog entries.

Adding Dental, Vision, And Hearing To Traditional Medicare Would Be Expensive, But Important

Congressional Democrats are expected to include a broad expansion of traditional Medicare benefits-- including dental, vision, and hearing—in a $3.5 trillion social spending bill they’ll consider later this year. The move would be the biggest expansion of Medicare since Congress added a drug benefit in 2003 and would go a long way toward improving the health and well-being of millions [...]

By |2021-07-22T10:47:23-04:00July 22nd, 2021|Medicare, Uncategorized|0 Comments

Will Medicare Pay For The New Alzheimer’s Drug?

Last month, The Food and Drug Administration (FDA) approved a controversial new drug to treat people with Alzheimer’s disease. But even though the FDA allowed the drug to be sold, Medicare is not required to pay for it. And yesterday, the Centers for Medicare & Medicaid Services (CMS) began a process to determine whether Medicare will establish a national coverage [...]

By |2021-07-13T13:57:06-04:00July 13th, 2021|dementia|0 Comments

Confronting the Growing Shortage of Care Workers For Older Adults

Every conversation I have with operators of senior living facilities and home care agencies quickly pivots to one issue: A desperate shortage of care workers. The problem isn’t new. Low pay, low status, and physically and emotionally demanding work has plagued the long-term care industry’s ability to hire for years. Highly restrictive Trump-era immigration policies further shrunk the supply of [...]

By |2021-07-06T16:13:08-04:00July 6th, 2021|long-term care, Uncategorized|0 Comments

Jumpstarting the Debate Over Public Long-Term Care Insurance

Rep Tom Suozzi (D-NY) has introduced a bill to create a public, catastrophic, long-term care insurance program. The monthly cash benefit, initially about $3,600 and indexed for inflation, would be funded with a modest increase in the payroll tax of 0.3 percent for workers and 0.3 percent for employers, or roughly $300-a-year for a median wage worker. For many older [...]

By |2021-07-01T11:41:01-04:00July 1st, 2021|long-term care financing|0 Comments

Where Long-Term Care Reform Goes Now

Last week, President Biden agreed to drop his proposed $400 billion increase in the federal share of Medicaid’s home-based long-term care services. He made the concession to reach a deal with a bipartisan group of 21 senators on a much broader physical infrastructure bill. But the flaws in the current system of supports and services for older adults and young [...]

By |2021-06-30T10:38:34-04:00June 30th, 2021|long term care reform|0 Comments

Covid-19 May Have Increased Nursing Home Deaths By Nearly One-Third

How bad was the covid-19 pandemic for nursing homes residents? A new government study finds that 40 percent had the virus, or probably did. About 169,000 more Medicare residents died in the pandemic year of 2020 than in 2019, an increase in the overall death rate of about 32 percent.  And in April 2020, about 1,000 more Medicare residents were [...]

By |2021-06-22T17:09:31-04:00June 22nd, 2021|nursing homes|0 Comments

FDA’s Approval Of A New Alzheimer’s Drug Shows What’s Wrong With The Way We Care For Frail Older Adults

FDA’s decision last week to approve a new “Alzheimer’s disease treatment,” and the buzz that surrounds it, is a symptom of all that is wrong with the way we care for frail older adults in the US. Rather than providing the supports that people with chronic conditions desperately need, and that evidence shows works, we prefer to chase butterflies. In [...]

By |2021-06-15T11:54:04-04:00June 15th, 2021|long-term care, Uncategorized|0 Comments

What Does FDA’s Approval Of A New Alzheimer’s Drug Mean?

In a highly controversial decision, the FDA gave accelerated approval to the first drug that could slow the progression of Alzheimer’s disease. But the approval does not say the FDA thinks the drug actually will treat the disease. Rather, FDA carefully states that the drug, with the chemical name aducanumab and the brand name Aduhelm, reduces a substance on the [...]

By |2021-06-07T17:50:37-04:00June 7th, 2021|dementia|5 Comments

Will Senate Moderates Sink Biden’s Medicaid Home-Based Long-Term Care Plan?

President Biden’s proposed massive expansion of Medicaid home-based long-term care is running into trouble in the Senate. And it may be done in, not by hard-core conservatives, but by a small group of self-styled Senate moderates. In his American Jobs Plan, Biden proposed increasing the federal share of Medicaid’s home and community-based services (HCBS) program by $400 billion—the largest increase [...]

By |2021-05-27T15:38:27-04:00May 27th, 2021|Medicaid|2 Comments

The Biden Administration Greenlights $12 Billion In Federal Medicaid Home Care Money. How Will States Spend It?

The Biden Administration has given the green light for states to begin to tap into about $12 billion in additional funding for Medicaid home-based long-term supports and services. In guidance issued to state Medicaid directors late last week, the federal Centers for Medicare and Medicaid Services (CMS) granted the states broad flexibility in how they use the money. The funds, [...]

By |2021-05-19T09:55:56-04:00May 19th, 2021|Medicaid|14 Comments